A combined molecular docking and molecular dynamics simulation approach to probing the host–guest interactions of Ataluren with natural and modified cyclodextrins

References

• Muntoni F, Desguerre I, Guglieri M, et al. Ataluren use in patients with nonsense mutation Duchenne muscular dystrophy: patient demographics and characteristics from the STRIDE registry. J Comp Eff Res. 2019;8(14):1187–1200.
   PubMed Web of Science ®Google Scholar
• Wilschanski M, Miller LL, Shoseyov D, et al. Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis. Eur Respir J. 2011;38(1):59–69.
   PubMed Web of Science ®Google Scholar
• Kerem E, Konstan MW, De Boeck K, et al. Ataluren for the treatment of nonsense-mutation cystic fibrosis: A randomised, double-blind, placebo-controlled phase 3 trial. Lancet Respir Med. 2014;2(7):539–547.
   PubMed Web of Science ®Google Scholar
• Ryan NJ. Ataluren: first global approval. Drugs. 2014;74(14):1709–1714.
   PubMed Web of Science ®Google Scholar
• Zainal Abidin N, Haq IJ, Gardner AI, et al. Ataluren in cystic fibrosis: development, clinical studies and where are we now? Expert Opin Pharmacother. 2017;18(13):1363–1371.
   PubMed Web of Science ®Google Scholar
• Peltz SW, Morsy M, Welch EM, et al. Ataluren as an agent for therapeutic nonsense suppression. Annu Rev Med. 2013;64(1):407–425.
   PubMedGoogle Scholar
• Lentini L, Melfi R, Di Leonardo A, et al. Toward a rationale for the PTC124 (Ataluren) promoted readthrough of premature stop codons: A computational approach and GFP-reporter cell-based assay. Mol Pharm. 2014;11(3):653–664.
   PubMed Web of Science ®Google Scholar
• Hajjari MM, Golmakani MT, Sharif N. Fabrication and characterization of cuminaldehyde-loaded electrospun gliadin fiber mats. LWT. 2021;145:111373.
   Web of Science ®Google Scholar
• Topuz F, Uyar T. Electrospinning of Cyclodextrin nanofibers: the effect of process parameters. J Nanomater. 2020;2020:1–10.
   Web of Science ®Google Scholar
• Del Valle EMM. Cyclodextrins and their uses: a review. Process Biochem. 2004;39(9):1033–1046.
   Web of Science ®Google Scholar
• Ryzhakov A, Do Thi T, Stappaerts J, et al. Self-Assembly of Cyclodextrins and their complexes in aqueous solutions. J Pharm Sci. 2016;105(9):2556–2569.
   PubMed Web of Science ®Google Scholar
• Sharif N, Golmakani M-T, Niakousari M, et al. Active food packaging coatings based on hybrid electrospun gliadin nanofibers containing ferulic acid/hydroxypropyl-beta-Cyclodextrin inclusion complexes. Nanomaterials. 2018;8(11):919.
   Web of Science ®Google Scholar
• Astray G, Gonzalez-Barreiro C, Mejuto JC, et al. A review on the use of Cyclodextrins in foods. Food Hydrocoll. 2009;23(7):1631–1640.
   Web of Science ®Google Scholar
• Gidwani B, Vyas A. A comprehensive review on cyclodextrin-based carriers for delivery of chemotherapeutic cytotoxic anticancer drugs. Biomed Res Int. 2015;2015:1–15.
   Web of Science ®Google Scholar
• Krabicová I, Appleton SL, Tannous M, et al. History of cyclodextrin nanosponges. Polymers. 2020;12(5):1122.
   Web of Science ®Google Scholar
• Loftsson T, Duchêne D. Cyclodextrins and their pharmaceutical applications. Int J Pharm. 2007;329(1-2):1–11.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins: basic science and product development. J Pharm Pharmacol. 2010;62(11):1607–1621.
   PubMed Web of Science ®Google Scholar
•  Lee JU, Lee SS, Lee S, et al. Noncovalent complexes of cyclodextrin with small organic molecules: applications and insights into host–guest interactions in the gas phase and condensed phase. Molecules. 2020;25(18):4048.
   Web of Science ®Google Scholar
• Hotarat W, Nutho B, Wolschann P, et al. Delivery of alpha-mangostin using cyclodextrins through a biological membrane: molecular dynamics simulation. Molecules. 2020;25(11):2532.
   Web of Science ®Google Scholar
• Arserı̇m Ucar KD. Smart nanocontainers for food safety, micro & nano technologies series, smart nanocontainers. Elsevier, 2020; p. 105–117.
   Google Scholar
• Aytac Z, Ipek S, Erol I, et al. Fast-dissolving electrospun gelatin nanofibers encapsulating ciprofloxacin/cyclodextrin inclusion complex. Colloids Surf B: Biointerfaces. 2019;178:129–136.
   PubMed Web of Science ®Google Scholar
• López CA, de Vries AH, Marrink SJ. Molecular mechanism of cyclodextrin mediated cholesterol extraction. PLoS Comput Biol. 2011;7:1–11.
   Web of Science ®Google Scholar
• Górnas P, Neunert G, Baczyński K, et al. Beta-Cyclodextrin complexes with chlorogenic and caffeic acids from coffee brew: spectroscopic, thermodynamic and molecular modelling study. Food Chem. 2009;114(1):190–196.
   Web of Science ®Google Scholar
• Singh RP, Hidalgo T, Cazade P-A, et al. Self-assembled cationic β-cyclodextrin nanostructures for siRNA delivery. Mol Pharm. 2019;16(3):1358–1366.
   PubMedGoogle Scholar
• Lopez CA, De Vries AH, Marrink SJ. Computational microscopy of cyclodextrin mediated cholesterol extraction from lipid model membranes. Sci Rep. 2013;3:1–6.
   Web of Science ®Google Scholar
• Piñeiro Á, Banquy X, Pérez-Casas S, et al. On the characterization of host-guest complexes: Surface tension, calorimetry, and molecular dynamics, of cyclodextrins with a non-ionic surfactant. J Phys Chem B. 2007;111(17):4383–4392.
   PubMed Web of Science ®Google Scholar
• Bikádi Z, Fodor G, Hazai I, et al. Molecular modeling of enantioseparation of phenylazetidin derivatives by cyclodextrins. Chromatographia. 2010;71(SUPPL. 1):21–28.
   Google Scholar
• Zhang H, Feng W, Li C, et al. Investigation of the inclusions of puerarin and daidzin with β-Cyclodextrin by molecular dynamics simulation. J Phys Chem B. 2010;114(14):4876–4883.
   PubMed Web of Science ®Google Scholar
• Zhang H, Tan T, Feng W, et al. Molecular recognition in different environments: β-Cyclodextrin dimer formation in organic solvents. J Phys Chem B. 2012;116(42):12684–12693.
   PubMed Web of Science ®Google Scholar
• Figueiras A, Sarraguça JMG, Pais AACC, et al. The role of l-arginine in inclusion complexes of omeprazole with cyclodextrins. AAPS PharmSciTech. 2010;11(1):233–240.
   PubMed Web of Science ®Google Scholar
• Fateminasab F, Bordbar AK, Shityakov S, et al. Comprehensive physico-chemical characterization of a serotonin inclusion complex with 2-hydroxypropyl-β-cyclodextrin. J Solut Chem. 2020a;49(7-8):915–944.
   Web of Science ®Google Scholar
• Fateminasab F, Bordbar AK, Shityakov S, et al. Molecular insights into inclusion complex formation between β- and γ-Cyclodextrins and rosmarinic acid. J Mol Liq. 2020b;314:113802.
   Web of Science ®Google Scholar
• Fateminasab F, Bordbar AK, Shityakov S. Detailed chemical characterization and molecular modeling of serotonin inclusion complex with unmodified β-cyclodextrin. Heliyon. 2019;5(4):e01405.
   PubMed Web of Science ®Google Scholar
• Fateminasab F, Bordbar AK, Shityakov S, et al. Diadzein complexation with unmodified cyclodextrins: a detailed experimental and theoretical study. J Mol Liq. 2018;271:80–95.
   Web of Science ®Google Scholar
• Sterling T, Irwin JJ. ZINC 15 - ligand discovery for everyone. J Chem Inf Model. 2015;55(11):2324–2337.
   PubMed Web of Science ®Google Scholar
• Berman HM, Westbrook J, Feng Z, et al. The protein data bank. Nucleic Acids Res. 2000;28(1):235–242.
   PubMed Web of Science ®Google Scholar
• Dennington R, Keith T, Millam J. Gaussview, version 5. Shawnee Mission (KS): Semichem Inc; 2009, p.Semichem Inc.
   Google Scholar
• Frisch MJ, Trucks GW, Schlegelet HB, et al. 2009. Wallingford CT: Gaussian 09, Gaussian, Inc. Wallingford CT. Gaussian, Inc. p. 2–3.
   Google Scholar
• Steffen C, et al. Autodock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem. 2010;31(16):2967–2970.
   PubMed Web of Science ®Google Scholar
• Van der Spoel D, Lindahl E, Hess B, et al. GROMACS: fast, flexible, and free. J Comput Chem. 2005;26:1701–1718.
   PubMed Web of Science ®Google Scholar
• Jing Huang Alexander D. MacKerell Jr. CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data. J Comput Chem. 2013;34:2135–2145.
   PubMed Web of Science ®Google Scholar
• Vanommeslaeghe K, MacKerell AD Jr. Automation of the CHARMM General Force Field (CGenFF) I: bond perception and atom typing. J Chem Inf Model. 2012;52(12):3144–3154.
   PubMed Web of Science ®Google Scholar
• Nosé S. A molecular dynamics method for simulations in the canonical ensemble. Mol Phys. 1984;52(2):255–268.
   Web of Science ®Google Scholar
• Hoover WG. Canonical dynamics: equilibrium phase-space distributions. Phys Rev A. 1985;31(3):1695–1697.
   PubMed Web of Science ®Google Scholar
• Parrinello M, Rahman A. Polymorphic transitions in single crystals: a new molecular dynamics method. J Appl Phys. 1981;52(12):7182–7190.
   Web of Science ®Google Scholar
• Hess B, Bekker H, et al. LINCS: A Linear Constraint Solver for molecular simulations. J. Comput. Chem. 1997;18:1463–1472.
   Web of Science ®Google Scholar
• Essmann U, Perera L, Berkowitz ML, et al. A smooth particle mesh Ewald method. J Chem Phys. 1995;103(1995):8577–8593.
   Google Scholar